X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/02/2855908/0/en/Vera-Therapeutics-Announces-Two-Oral-Presentations-at-the-61st-European-Renal-Association-Congress.html
https://www.globenewswire.com/news-release/2024/03/20/2849276/0/en/Vera-Therapeutics-Provides-Business-Update-and-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/28/2837475/0/en/Vera-Therapeutics-to-Participate-at-the-44th-Annual-TD-Cowen-Health-Care-Conference.html
https://www.globenewswire.com//news-release/2024/02/02/2822819/0/en/Vera-Therapeutics-to-Participate-in-the-Guggenheim-Healthcare-Talks-6th-Annual-Biotechnology-Conference.html
https://www.globenewswire.com//news-release/2024/02/01/2822432/0/en/Vera-Therapeutics-Announces-Closing-of-Upsized-Public-Offering-and-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares-in-Public-Offering-of-Class-A-Common-Stock.html
https://ir.veratx.com/news-releases/news-release-details/vera-therapeutics-announces-proposed-public-offering-class
https://www.globenewswire.com/news-release/2024/01/30/2819568/0/en/Vera-Therapeutics-Announces-Pricing-of-Upsized-Public-Offering-of-Class-A-Common-Stock.html
https://www.globenewswire.com//news-release/2024/01/25/2816523/0/en/Vera-Therapeutics-Presents-Positive-72-Week-Data-Showing-eGFR-Stabilization-in-the-Phase-2b-ORIGIN-Clinical-Trial-OLE-in-IgA-Nephropathy.html
https://www.globenewswire.com//news-release/2024/01/08/2805421/0/en/Vera-Therapeutics-Announces-Appointment-of-Industry-Veterans-Robert-Brenner-M-D-as-Chief-Medical-Officer-and-William-D-Turner-as-Chief-Development-Officer.html
https://www.globenewswire.com//news-release/2024/01/08/2805408/0/en/Vera-Therapeutics-to-Host-In-Person-R-D-Day-in-New-York-to-Present-Week-72-Data-from-Phase-2b-ORIGIN-Clinical-Trial-of-Atacicept-in-IgAN-on-January-25-2024.html
Market Place
Share 
